bio.logis GIMS - Home of the Clinical Interpretome
News
| Artikel
GIMS.pharma supports implementation of pharmacogenomics at point of care
Medicines do not have the same effect on all patients. Because many factors affect drug response, physicians must select a drug that is appropriate for each individual and carefully adjust the dose. What many do not know and therefore often not considered in drug therapy: variants of DNA can lead to unwanted or insufficient drug effects (ADR).
Events
| Konferenz
Be part of the ESPT Congress, starting Oct 16 in Seville!
ESPT meeting brings together leading international scientists and healthcare professionals who are actively working in the fields of pharmacogenomics and personalised therapy.
Testimonials
„We are convinced, that the Diagnostic Report Module of the bio.logis Genetic Information Management Suite will improve the process of creating more valuable results, which we provide to our clients (i.e. physicians). This will help us to build a competition advantage.“
Participation in EU-Projects within Horizon 2020 program
- Ubiquitous Pharmacogenomics (U-PGx)
- Genetics Clinic of the Future (GCOF)
Partners
